Sepul Bio Completes Enrollment in Phase 2b LUNA Clinical Trial of Ultevursen for USH2A-Associated Retinitis Pigmentosa
“Achieving the enrollment of the final participant in the Phase 2b LUNA clinical trial represents a fantastic milestone for USH2A research,” said Dr. Robert Koenekoop, MD, PhD, Professor in the Department of Pediatric Surgery at the Faculty of Medicine and Health Sciences, McGill University. “This moment takes us one step closer in our search for […]





























